NCT02923778

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2019-12-31Est. Completion: 2026-12-29

Enrollment target: 40 participants

Locations

Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States
City of Hope Comprehensive Cancer Center, Duarte, California, United States
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
Mayo Clinic in Florida, Jacksonville, Florida, United States
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
Moffitt Cancer Center, Tampa, Florida, United States
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States
Washington University School of Medicine, St Louis, Missouri, United States
Siteman Cancer Center-South County, St Louis, Missouri, United States
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire, United States
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

Solid TumorSarcomaLeiomyosarcomaDedifferentiated Liposarcoma

This early phase oncology trial will be conducted at various study centers to investigate the safety, tolerability, and …

San Francisco, United StatesEst. completion Dec 29, 2027

Leiomyosarcoma

The purpose of this study is to find out if Ivonescimab is an effective and safe treatment that causes few or mild side …

Basking Ridge, United StatesEst. completion Apr 2029

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.